Categories: Wire Stories

Cough, Cold and Allergy (Hay Fever) Remedies in Australia: COVID-19 Pandemic is Having a Polarising Demand in 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cough, Cold and Allergy (Hay Fever) Remedies in Australia” report has been added to ResearchAndMarkets.com’s offering.

The pandemic is having a polarising impact on demand for cold, cough and allergy (hay fever) remedies in 2021. While COVID-19 measures including social distancing rules, use of protective face masks and hand sanitisers were put in place to limit the spread of the virus in Q1 and Q2 2021, these restrictions have also been limiting the spread of common influenza symptoms in Australia.

The report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage:

Antihistamines/Allergy Remedies (Systemic), Combination Products – Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage:

Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Key report benefits:

  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Key Topics Covered:

HEADLINES

2021 DEVELOPMENTS

  • Cold, cough and allergy (hay fever) remedies experiences polarising trends in 2021
  • Australians remain prepared to tackle various health concerns
  • Despite challenging market conditions, Johnson & Johnson retains leadership of cough, cold and allergy (hay fever) remedies in 2021

PROSPECTS AND OPPORTUNITIES

  • Technological breakthrough with influenza vaccine likely to impact demand for cough, cold and allergy (hay fever) remedies
  • Segmentation as a strategy to add value
  • Climate to maintain demand for antihistamines/allergy remedies (systemic) over the forecast period

CATEGORY DATA

CONSUMER HEALTH IN AUSTRALIA

EXECUTIVE SUMMARY

  • Consumer health in 2021: The big picture
  • 2021 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?

MARKET INDICATORS

MARKET DATA

For more information about this report visit https://www.researchandmarkets.com/r/xzu25p

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Alex

Recent Posts

The Top 10 Best Places to Work in Egypt for 2024 revealed

CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…

2 hours ago

Trend Micro Named a Magic Quadrant Leader for Email Security Platforms

Trend Vision One™ – Email and Collaboration Security is a critical part of Trend’s centralized…

3 hours ago

Hollywood’s Style Icon Zendaya Makes Her Stunning Wax Debut at Madame Tussauds Singapore

SINGAPORE - Media OutReach Newswire - 23 December 2024 - Madame Tussauds Singapore is proud…

5 hours ago

Star-Studded Christmas Music Gala Lights Up the Stage

TAIPEI, TAIWAN - Media OutReach Newswire - 23 December 2024 – The 2024 Christmasland in…

8 hours ago

Graphisoft Strengthens Presence in Southeast Asia Amid BIM Demand Surge

Hungarian-based technology leader underscores its commitment to education, sustainability, and innovation SINGAPORE - Media OutReach…

9 hours ago